The serum levels of IL-6, which is directly associated with early glomerular structural abnormalities, have been shown to be substantially higher in type 2 diabetes mellitus (T2DM) patients with DN than in T2DM patients without renal disease. Here, IL6 is linked to diabetes mellitus.